|

Elastography-based Brief Alcohol Intervention in Hospitalized Individuals

RECRUITINGN/ASponsored by Oslo University Hospital
Actively Recruiting
PhaseN/A
SponsorOslo University Hospital
Started2026-09-14
Est. completion2030-05-15
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Harmful alcohol use is a common cause of hospital admissions and the leading cause of liver cirrhosis. Timely detection of liver disease is crucial to prevent liver disease progression and reduce alcohol-related harms. The hypothesis is that proactive assessment of liver health during hospitalization may motivate reductions in alcohol use and thereby prevent disease complications and recurrent admissions more effectively than usual care. The study will recruit 500 patients at risk of alcohol-related liver disease who are admitted for inpatient care for any reason. Recruitment will be done at 8 Norwegian hospitals over an 18-month period. Participants will be randomized to liver elastography (liver stiffness measurement) and personalized alcohol counselling, or to usual care. After discharge, participants will be followed with study visits after 3, 6 and 12 months. Assessments during follow-up include self-reported alcohol use, the alcohol biomarker PEth and health-related quality of life. The primary outcome is the number of emergency hospital admissions for any reason within 2 years, collected from the Norwegian Patient Registry. The study has very low risk for the participants, with no invasive procedures or risks associated with the intervention. The potential benefit is considerably greater, with opportunities for improved health, prognosis, and quality of life for a large patient group for whom effective interventions are largely lacking. The study has very low risk for the participants, with no invasive procedures or risks associated with the intervention. The potential benefit is considerably greater, with opportunities for improved health, prognosis, and quality of life for a large patient group for whom effective interventions are largely lacking.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Emergency hospitalized for any reason in any participating centre
2. Adults 18 years or older
3. Harmful alcohol use, defined as AUDIT-C ≥6 (for men) or AUDIT-C ≥5 (for women)
4. Moderate to high risk of liver fibrosis, defined as FIB-4 \>1.3
5. Signed informed consent

Exclusion Criteria:

1. Decompensated liver disease that impedes intervention delivery, defined as one or more of the following:

   1. Moderate or severe ascites
   2. Overt hepatic encephalopathy (West Haven grade ≥2)
   3. Acute-on-chronic liver failure requiring admission to intensive care unit
2. Acute hepatitis of any aetiology, defined as ALT or AST \>5 x upper limit of normal (ULN)
3. Unable to participate for any reason in the opinion of the investigator

Conditions3

Alcohol Use DisorderAlcoholic Liver Disease (ALD)Liver Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.